Multimodality therapy for high-risk endometrial cancer: balancing the courses while keeping all options on the table
Burnett, O.Lee.; De lo Santos, J.F.
Oncology 27(10): 1001 1006 1011
2013
ISSN/ISBN: 0890-9091 PMID: 24367858 Document Number: 668242
Document emailed within 1 workday
Related Documents
Mangili, G.; De Marzi, P.; Viganò, R.; Rabaiotti, E.; Sassi, I.; Taccagni, G.L.; Garancini, P.; Frigerio, L. 2002: Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer European Journal of Gynaecological Oncology 23(3): 216-220Abu Hmeidan, F.; Bilek, K.; Baier, D.; Nuwayhid, M.; Kade, R. 1992: Ultrasound assessment of the endometrium in early detection of endometrial cancer in high risk patients Zentralblatt für Gynakologie 114(9): 455-458
Kiseleva, V.N.; Savinova, V.F.; Mar'ina, L.A.; Chekhonadskiĭ, V.N. 1988: Neutron therapy of endometrial cancer using californium-252 sources of high activity Voprosy Onkologii 34(9): 1070-1074
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21
Felix, A.S.; Gaudet, M.M.; La Vecchia, C.; Nagle, C.M.; Shu, X.O.; Weiderpass, E.; Adami, H.O.; Beresford, S.; Bernstein, L.; Chen, C.; Cook, L.S.; De Vivo, I.; Doherty, J.A.; Friedenreich, C.M.; Gapstur, S.M.; Hill, D.; Horn-Ross, P.L.; Lacey, J.V.; Levi, F.; Liang, X.; Lu, L.; Magliocco, A.; McCann, S.E.; Negri, E.; Olson, S.H.; Palmer, J.R.; Patel, A.V.; Petruzella, S.; Prescott, J.; Risch, H.A.; Rosenberg, L.; Sherman, M.E.; Spurdle, A.B.; Webb, P.M.; Wise, L.A.; Xiang, Y.-B.; Xu, W.; Yang, H.P.; Yu, H.; Zeleniuch-Jacquotte, A.; Brinton, L.A. 2015: Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium International Journal of Cancer 136(5): E410-E422
Wen, H.-w.; Tian, F.; Ma, L.; Liao, Q.-p. 2009: Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer Zhonghua Fu Chan Ke Za Zhi 44(3): 196-199
Audet-Lapointe, P.; Ayoub, J.; Methot, Y. 1988: An innovative protocol, cyclic hormone-chemotherapy in the treatment of high-risk localized endometrial cancer Journal de Gynecologie Obstetrique et Biologie de la Reproduction 17(6): 751-755
Tu, S.-M.; Lin, S.-H.; Podoloff, D.A.; Logothetis, C.J. 2010: Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer Clinical Advances in Hematology and Oncology: H&o 8(5): 341-351
Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
1974: Round table discussion about lipids in ischemic heart diseases: the importance of diagnosing and observing high risk families. The value of lowering high blood lipid levels Nordisk Medicin 89(9): 281-288
Raben, D.; Williams, J.; Abrams, R.A. 1994: The clinical use of multimodality therapy in the management of cancer In Vivo 8(5): 635-642
Hausknecht, R.U.; Gusberg, S.B. 1969: Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma American Journal of Obstetrics and Gynecology 105(8): 1161-1167
Morimoto, O.; Takiuchi, D.; Wada, R.; Higashiguchi, M.; Nishida, K.; Wada, N.; Munakata, K.; Sakata, K.; Akamaru, Y.; Ota, H.; Shibata, K.; Ohashi, H. 2017: Multimodality Therapy for Cecal Cancer with Peritoneal Dissemination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 2011-2013
Hooker, A.B.; Radder, C.M.; van de Wiel, B.; Geenen, M.M. 2011: Metastasis from breast cancer to an endometrial polyp; treatment options and follow-up. Report of a case and review of the literature European Journal of Gynaecological Oncology 32(2): 228-230
Koyama, M.; Murata, A.; Sakamoto, Y.; Morohashi, H.; Hasebe, T.; Saito, T.; Awatsu, A.; Abo, E.; Terui, K.; Hakamada, K. 2014: Surgical treatment outcomes of multimodality therapy for locally recurrent rectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1459-1461
Goldberg, M. 2000: Multimodality therapy in surgically resectable early non-small cell lung cancer In Vivo 14(1): 51-60
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106
Yamamoto, S.; Ohshima, H.; Katsumori, T.; Hamaguchi, H.; Tsukamoto, Y.; Iwanaga, T. 2017: Two Cases of Stage IV Pancreatic Cancer Has Gained Relatively Long Free Survival in Multimodality Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1778-1780
Duron-Alirol, M. 1990: Round table discussion. High-risk pregnancies. Cooperative work between the puericulturists and the midwives Soins. Gynecologie Obstetrique Puericulture Pediatrie 1990(113): 37-40
Buyyounouski, M.K. 2010: Androgen deprivation therapy in high-risk prostate cancer Oncology 24(9): 806; 809